Restoration of energy metabolism in leukemic mice treated by a siddha drug-Semecarpus anacardium Linn. nut milk extract

Chemico-Biological Interactions

Volumn 173, Issue 1, 2008, Pages 43-58

  Sugapriya, Dhanasekaran ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanatham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

12B1 cell line; BCR ABL fusion gene; Glycolytic enzymes; Mitochondrial enzymes; Murine leukemic model; Semecarpus anacardium

Indexed keywords

BCR ABL PROTEIN; FLAVONOID; GLYCOLYTIC ENZYME; IMATINIB; LIPID PEROXIDE; MITOCHONDRIAL ENZYME; POLYPHENOL; SEMECARPUS ANACARDIUM EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST CELL CRISIS; BLOOD SMEAR; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARBOHYDRATE METABOLISM; CHRONIC MYELOID LEUKEMIA; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; MONOTHERAPY; MOUSE; NONHUMAN; RESPIRATORY CHAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMECARPUS;

ANIMALS; BASE SEQUENCE; BODY WEIGHT; BONE MARROW; DNA PRIMERS; ENERGY METABOLISM; FEMALE; FUSION PROTEINS, BCR-ABL; LEUKEMIA, EXPERIMENTAL; LIPID PEROXIDES; LIVER; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT EXTRACTS; RNA, MESSENGER; SEMECARPUS; SPLEEN;

ANIMALIA; MURINAE; MUS; SEMECARPUS ANACARDIUM;

EID: 41949104961     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.01.013     Document Type: Article

References (75)

1. Rabinowitz I., and Larson R.S. Wintrobe's Clinical Hematology. In: Greer J.P., Foerster J., and Lukens J.N. (Eds). Chronic Myeloid leukemia (2004), Lippincott Williams & Wilkins 2236-2258
2. Nowell P.C., and Hungerford D.A. A minute Chromosome in human chronic granulocyte leukemia. Science 132 (1960) 1497 (Abstract)
3. Rowley D.A., and Halliwell B. Superoxide-dependent and ascorbate dependent formation of hydroxyl radicals in the presence of copper salts: a physiologically significant reaction?. Arch. Biochem. Biophys. 225 (1983) 279-284
4. McLaughlin J., Chianese E., and Witte O.N. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 84 (1987) 6558-6562
5. He L., Feng H., Raymond A., Kreeger M., Zeng Y., Graner M., While Sell L., and Katsanis E. Dendritic-cell-peptide immunization provides immunoprotection against BCR-ABL positive leukemia in mice. Cancer Immunol. Immunother. 50 (2001) 31-40
6. Sobotkova E., Ludvikova V., Petrakova M., Duskova M., Smetana K., Jelinek F., Marinov I., and Vonka V. Characteristic of two mouse bcr-abl-transformed cell lines: I. General properties of the cells. Folia Biol. (Praha) 51 (2005) 12-18 Erratum in: Folia Biol. (Praha) 51 (2005) 158-164
7. Jelinek F., Sobotkova E., and Vonka V. Characteristics of two mouse bcr-abl-transformed cell lines. II. Pathological lesions induced in mice. Folia Biol. (Praha) 5 (2005) 102-193
8. Shoffner T.M., and Wallace D.C. Oxidative phosphorylation disease and mitochondrial DNA mutations: diagnosis and treatment. Annu. Rev. Nutr. 14 (1994) 535-568
9. Hartwell J.L. Types of anticancer agents isolated from plants. Cancer Treat. Rep. 60 (1976) 1031-1067
10. Premalatha B., and Sachdanandam P. Semecarpus anacardium Linn. nut extract administration induces the in vivo antioxidant defence system in aflatoxin B1 mediated hepatocellular carcinoma. J. Ethnopharmacol. (1999) 131-139
11. Indap M.A., Ambaye R.Y., and Gokale S.V. Antitumor and Pharmacological effects of the oil from Semecarpus anacardium Linn. Indian J. Physiol. Pharmacol. 27 (1983) 83-86
12. Chakraborty S., Roy M., Taraphdar A.K., and Bhattacharya R.K. Cytotoxic effect of root extract of Tiliacora racemosa and oil of Semecarpus anacardium nut in human tumor cells. Phytotherapy 18 (2004) 595-600
13. Murthy S.N.N. A biflavonoid form Semecarpus anacardium. Phytochemistry 22 (1983) 1518-1520
14. Murthy S.N.N. Jeediflavanone-a biflavanoid from Semecarpus anacardium. Phytochemistry 24 (1985) 1065-1069
15. Murthy S.N.N. Naturally occurring biflavanoid derivatives part VII galluflavanone a new flavanoid from Semecarpus anacardium Linn. Indian J. Chem. 24B (1985) 398-404
16. Murthy S.N.N. Naturally occurring biflavonoid derivatives part IX New dimeric flavone from Semecarpus anacardium Linn. Proc. Indian Natl. Sci. Acad. Part A 53 (1987) 632-636
17. Murthy S.N.N. Naturally occurring biflavonid derivatives. Part X Semecarpetin, a biflavonone from Semecarpus anacardium. Photochemistry 27 (1988) 3020-3022
18. Murthy S.N.N. New biflavonoid from Semecarpus anacardium Linn. Clin. Acta Turcica 20 (1992) 33-37
19. Vijayalakshmi T., Muthulakshmi V., and Sachdanandam P. Effect of milk extract of Semecarpus anacardium nut on adjuvant arthritis-a dose dependent study in Wistar albino rats. Gen. Pharmacol. 27 (1996) 1223-1229
20. Sujatha V., and Sachdanandam P. Recuperative effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats. Phytother. Res. 16 (2002) S14-S18
21. Mathivadhani P., Shanthi P., and Sachdanandam P. Apoptotic effect of Semecarpus anacardium nut extract on T47D breast cancer cell line. Cell Biol. Int. 31 (2007) 1198-1206
22. Ramprasath V.R., Shanthi P., and Sachdanandam P. Evaluation of antioxidant effect of Semecarpus anacardium Linn. nut extract on the components of immune system in adjuvant arthritis. Vascul. Pharmacol. 42 (2005) 179-186
23. Hollman P.C.H., and Katan M.B. Health effects and bioavailability of dietary flavonoids. Free Radic. Res. 31 (1999) S75-S80
24. Ames B.N., Shingenaga M.K., and Hagen T.M. Oxidants antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90 (1993) 7915-7922
25. Selvam C., and Jachak S.M. Acyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium. J. Ethnopharm. 95 (2004) 209-212
26. Sharma K., Shukla S.D., Mehta P., and Bhatnagar M. Fungistatic activity of Semecarpus anacardium Linn. nut extract. Indian J. Exp. Biol. 40 (2002) 314-318
27. Premalatha B., and Sachdanandam P. Stabilization of lysosomal membrane and cell membrane glycoprotein profile by Semecarpus anacardium Linn. nut milk extract in experimental hepatocellular carcinoma. Phytother. Res. 14 (2000) 352-355
28. Formulary of Siddha Medicine. second ed. (1972), The Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd., India p. 197
29. Zeng Y., Graner M.W., Feng H., Li G., and Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl-murine leukemia. Int. J. Cancer 110 (2004) 251-259
30. Swirsky D., and Bain B. Dacie and Lewis practical hematology. In: Lewis M., Bain B.J., and Bates I. (Eds). Erythrocyte and Leukocyte Cytochemistry-Leukemia Classification. ninth ed. (2001), Churchill Livingstone 285-287
31. Bancroft D.J., and Cook C.H. Fundamentals of normal histology and histopathology. In: Bancroft D.J., and Cook C.H.I. (Eds). Manual of Histopathological Techniques and Their Diagnostic Application (1994), Churchill Livingstone 1-17
32. Senior A.E., McGowan S.E., and Hilf R. A comparative study of inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumor and normal rat mammary gland. Cancer Res. 35 (1975) 2061-2067
33. Slater E.C., and Bonner W.D. Inhibition of the succinic oxidase system by fluoride. Biochem. J. 49 (1951) 185-196
34. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall A.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
35. Devasagayam T.P., and Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem. Biophys. Res. Commun. 145 (1987) 469-474
36. Branstrup N., Krik J.E., and Bruni C.J. The hexokinase and phosphoglucoisomerase activities of aorta and pulmonary artery tissue in individuals of various ages. Gerontology 12 (1957) 166-171
37. King J. In: King J. (Ed). Practical and Clinical Enzymology. The Transferases Alanine and Aspartate Transaminases (1965), D. Van Nostrand Co. Ltd., London 121-138
38. King J. In: King J. (Ed). Practical and Clinical Enzymology. The Phosphohydrolases Acid and Alkaline Phosphatases (1965), D. Van Nostrand Co. Ltd., London 191-208
39. Gancedo J.M., and Gancedo C. Fructose-1-6-bisphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase. Proc. Soc. Exp. Biol. Med. 106 (1971) 607-609
40. Bernt E., and Bergmeyer H.V. Methods of Enzymatic Analysis (1974), Academic Press, New York
41. Reed L.J., and Mukherjee R.B. A ketoglutarate dehydrogenase complex from Escherichia coli. Methods Enzymol. 13 (1969) 55-61
42. Mehler A.H., Kornberg A., Grisolia S., and Ochoa S. The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate. J. Biol. Chem 714 (1948) 961-977
43. Minakami S., Ringer R.L., and Singer T.P. The enzymatic mechanism of oxidation ± reductions between malate or isocitrate and pyruvate. J. Biol. Chem. 237 (1962) 569-576
44. Wharton D.C., and Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10 (1967) 245-250
45. Cheung C.F., Chung K.W., Lui J.K., Lau C.P., Hon P.M., Chan J.W., Fung K.P., and Au S.N. Leachianone A as a potential anticancer drug by induction of apoptosis in human hepatoma HepG2 cells. Cancer Lett. 253 (2007) 224-235
46. Boros L.G., and Lee W.N. Cascante M Imatinib and chronic-phase leukemias. N. Engl. J. Med. 347 (2002) 67-78
47. Sujun L., Jie Z., Daxu L., Wei L., Xun L., Rongxian Z., Li L., and Jian Z. Anticancer activity and quantitative analysis of flavone of Cirsium japonicum. Nat. Prod. Res. 21 (2007) 915-922
48. Chen D., Chen M.S., Yang Q.C., and Dou Q.P. Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells. Front. Biosci. 12 (2007) 1935-1945
49. Argiles J.M., and Azcon-Bieto J. The metabolic environment of cancer. Mol. Cell. Biochem. 81 (1988) 3-17
50. Tessitore L., Costelli P., and Baccino F.M. Pharmacological interference with tissue hypercatabolism in tumor-bearing rats. Biochem. J. 299 (1994) 71-78
51. Martignoni M.E., Philipp K., and Helmut F. Cancer cachexia. Mol. Cancer 2 (2003) 36
52. Kawamura T., Ohisa Y., Abe Y., Ishimori A., Shineha R., and Yokota K. Plasma lipid peroxides in the operation of oesophageal cancer. Rinsho-Ayori 40 (1992) 881-884 (in Japanese)
53. Yagi K. Lipid peroxides and human diseases. Chem. Phys. Lipids 45 (1987) 337-351
54. Scott M.D., Eatonm J.N., Frans A.K., Daniel T., Chiu Y., and Lubin B.H. Enhancement of erythrocyte SOD activity effects on cellular oxidant defence. Blood 74 (1989) 2542-2549
55. Szewezyk A., and Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 54 (2002) 101-127
56. Hennipman A., Oirschot B.A.V., Smits J., Rijksen G., and Staal G.E. Glycolytic enzyme activities in breast cancer metastases. Tumour Biol. 9 (1988) 241-248
57. Sathyavathi G.V., Prasad D.N., and Das P.K. Anti-inflammatory activity of Semecarpus anacardium Linn. A preliminary study. Indian J. Physiol. Pharmacol. 13 (1969) 37-45
58. Klopman G., and Dimayuga M.L. Computer-automated structure evaluation of flavonoids and other structurally-related components as glyoxalase enzyme inhibitors. Mol. Pharmacol. 34 (1988) 218-222
59. Sigers C.P., and Younes M. Effect of bioflavonoids on lipid peroxidation induced by GSH depletion. Proc. Int. Bioflavonoids Symposium (1981), Kuwch, FRG 403-409
60. Kasapoglu M., and Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp. Gerontol. 36 (2000) 209-220
61. Bohm H., Boeing H., Hempel J., Raab B., Kroke A., and Ernahrungswiss Z. Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases. Z. Ernahrungswiss 37 2 (1998) 147-163
62. Fridovich I. The biology of oxygen radicals. Science 201 (1978) 875-880
63. Golshani-Hebroni S.G., and Bessman S.P. Hexokinase binding to mitochondria, a basis for proliferative energy metabolism. J. Bioenerg. Biomembr. 29 (1997) 331-338
64. Gudnason V., Ingvarsson S., Jonasdottir A., Andresdottir V., and Egilsson V. Isoenzyme pattern and subcellular localization of hexokinases in human breast cancer and nonpathological breast tissue. Int. J. Cancer 34 (1984) 63-66
65. Suolinna M., Buchsbaum R.N., and Racker E. The effect of flavonoids and aerobic glycolysis and growth of tumor cells. Cancer Res. 35 (1975) 1865-1872
66. Havsteen B. Flavonoids, a class of natural products of high pharmacology potency. Biochem. Pharm. 32 (1983) 1141-1148
67. Arathi G., and Sachdanandam P. Therapeutic effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing and mitochondrial TCA cycle and respiratory chain enzymes in mammary carcinoma rats. J. Pharm. Pharmacol. 55 (2003) 1283-1290
68. Weber G., and Morris H.P. Comparative biochemistry of hepatomas 1 Carbohydrate enzymes in Morris hepatoma 5123. Cancer Res. 21 (1961) 933-937
69. Park E., Wagenbichler P., and Elmadfa I. Effects of multivitamin/mineral supplementation, at nutritional doses, on plasma antioxidant status and DNA damage estimated by sister chromatid exchanges in lymphocytes in pregnant women. Int. J. Vitam. Nutr. Res. 69 (1999) 396-402
70. Pederson P.L. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22 (1978) 190-274
71. Hodnick W.F., Kung F.S., Roettger W.J., Bohmont C.W., and Pardini R.S. Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. A structure-activity study. Biochem. Pharmacol. 35 (1986) 2345-2357
72. Galati G., and O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 37 (2004) 287-303
73. Williams R.J., Spencer J.P., and Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 36 (2004) 838-849
74. Kim D.O., and Lee C.Y. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit. Rev. Food Sci. Nutr. 44 (2004) 253-273
75. She Q.B., Bode A.M., Ma W.Y., Chen N.Y., and Dong Z. Resveratrol induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61 (2001) 1604-1610